International Journal of Reproductive BioMedicine

Published date: Mar 10 2025

Journal Title: International Journal of Reproductive BioMedicine

Issue title: International Journal of Reproductive BioMedicine (IJRM): Volume 23, Issue No. 1

Pages: 55 - 66

DOI: 10.18502/ijrm.v23i1.18185

Elham AbbasiDepartment of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad

Morteza Behnam Rassoulibehnam@um.ac.irDepartment of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad

Ali MoghimiDepartment of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad

Zeinab NeshatiDepartment of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad

Background: Successful reproduction relies on a functioning hypothalamic-pituitary-gonad axis. Damage to this axis disrupts the estrus cycle and reproductive capability.

Objective: This study aimed to evaluate the effects of single or multiple platelet-rich plasma (PRP) injections on repairing the damaged hypothalamic arcuate nucleus (ARC) and restoring the estrus cycle in Wistar rats.

Materials and Methods: 90 female Wistar rats (2–3 months old, 250–280 gr) with regular estrous cycles were divided into a control group and 8 experimental groups (n = 10/each). After bilateral stereotaxic chemical surgery of the ARC using quinolinic acid (500 nmol/2 μl), the experimental rats were categorized into several treatment regimens: ARC⁻ (no treatment), 1 PRP injection (immediately, 24 hr, 48 hr, and 72 hr postsurgery), 2 PRP injections (immediately, 24 hr), 3 PRP injections (immediately, 24 hr, and 48 hr), and 4 PRP injections (immediately, 24 hr, 48 hr, and 72 hr). Vaginal smear cytology was performed daily for 2.5 months. In the end, rats brains were removed and divided for real-time polymerase chain reaction analysis of kisspeptin, neurokinin B, and dynorphin, as well as for ARC cell counting. Results: Vaginal smear cytology indicated that PRP administration gradually restored the estrous cycle. Compared to the ARC⁻ group, PRP treatment significantly increased ARC cell density (p = 0.012) and mRNA levels of kisspeptin, neurokinin B, and dynorphin (p < 0.001).

Conclusion: These findings not only emphasized the importance of the ARC for the regularity of estrous cycle but also showed the potential effects of local PRP treatment in contribution to the protection/reconstruction of ARC.

Keywords: Arcuate nucleus, Estrus cycle, PRP, Rat

[1] Zakharova L, Sharova V, Izvolskaia M. Mechanisms of reciprocal regulation of gonadotropin-releasing hormone (GnRH)-producing and immune systems: The role of GnRH, cytokines and their receptors in early ontogenesis in normal and pathological conditions. Int J Mol Sci 2020; 22: 114.

[2] Plant TM, Steiner RA. The fifty years following the discovery of gonadotropin-releasing hormone. J Neuroendocrinol 2022; 34: e13141.

[3] Terasawa E. Mechanism of pulsatile GnRH release in primates: Unresolved questions. Mol Cell Endocrinol 2019; 498: 110578.

[4] Vieyra E, García JC, Zarco HA, Linares R, Rosas G, Ramírez DA, et al. Suprachiasmatic nucleus and vagus nerve trigger preovulatory LH and ovulation. Reproduction 2023; 165: 147–157.

[5] Patel B, Koysombat K, Mills EG, Tsoutsouki J, Comninos AN, Abbara A, et al. The emerging therapeutic potential of kisspeptin and neurokinin B. Endocrine Rev 2024; 45: 30–68.

[6] Prashar V, Arora T, Singh R, Sharma A, Parkash J. Hypothalam Kisspeptin neurons: Integral elements of the GnRH system. Reprod Sci 2023; 30: 802–822.

[7] Moore AM, Novak AG, Lehman MN. KNDy neurons of the hypothalamus and their role in GnRH pulse generation: An update. Endocrinology 2024; bqad194.

[8] Iwata K, Ogata R, Sato M, Matsuda F, Ishii H, Ozawa H. Short-term depletion of plasma estrogen affects hypothalamic kisspeptin-neurokinin B-dynorphin a neurons, gonadotrophs, and pulsatile luteinizing hormone secretion in female rats. Peptides 2023; 160: 170929.

[9] Sobrino V, Avendano MS, Perdices-Lopez C, Jimenez-Puyer M, Tena-Sempere M. Kisspeptins and the neuroendocrine control of reproduction: Recent progress and new frontiers in kisspeptin research. Front Neuroendocrinol 2022; 65: 100977.

[10] Hu R, Huang Y, Geng Y, Li Zh, Li F, Zhang Zh, et al. Jiawei Buzhong Yiqi decoction ameliorates polycystic ovary syndrome via oocyte-granulosa cell communication. J Ethnopharmacol 2024; 323: 117654.

[11] Feyzollahi Z, Mohseni Kouchesfehani H, Jalali H, Eslimi-Esfahani D, Sheikh Hosseini A. Effect of Vitex agnus-castus ethanolic extract on hypothalamic KISS-1 gene expression in a rat model of polycystic ovary syndrome. Avicenna J Phytomed 2021; 11: 292–301.

[12] Luo Sh, Ezrokhi M, Cominos N, Tsai T-H, Stoelzel CR, Trubitsyna Y, et al. Experimental dopaminergic neuron lesion at the area of the biological clock pacemaker, suprachiasmatic nuclei (SCN) induces metabolic syndrome in rats. Diabetol Metab Syndrome 2021; 13: 11.

[13] Nikolovska B, Miladinova D, Pejkova S, Trajkova A, Georgieva G, Jovanoski T, et al. Platlet-rich plasma: Review of literature. Pril 2021; 42: 127–139.

[14] Gentile P, Garcovich S. Systematic rev the potential implications of different platelet-rich plasma (PRP) concentrations in regenerative medicine for tissue repair. Int J Mol Sci 2020; 21: 5702.

[15] Xiong Y, Gong Ch, Peng X, Liu X, Su X, Tao X, et al. Efficacy and safety of platelet-rich plasma injections for the treatment of osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. Front Med 2023; 10: 1204144.

[16] Ismail D, Farag E. A histological study on platelet poor plasma versus platelet rich plasma in amelioration of induced diabetic neuropathy in rats and the potential role of telocyte-like cells. Egypt J Histol 2021; 44: 8–30.

[17] Saremi J, Mahmoodi N, Rasouli M, Esmaeili Ranjbar F, Lak Mazaheri E, Akbari M, et al. Advanced approaches to regenerate spinal cord injury: The development of cell and tissue engineering therapy and combinational treatments. Biomed Pharmacother 2022; 146: 112529.

[18] Zhu Y, Jin Zh, Fang J, Wang J, Wang Y, Song Q, et al. Platelet-rich plasma combined with low-dose ultrashort wave therapy accelerates peripheral nerve regeneration. Tissue Eng Part A 2020; 26: 178–192.

[19] Purushothaman B, Sumathi T. 5, 6, 7 trihydroxy flavone armoured neurodegeneration caused by quinolinic acid induced huntington’s like disease in rat striatum-reinstating the level of brain neurotrophins with special reference to cognitive-socio behaviour, biochemical and histopathological aspects. Neurosci Res 2022; 174: 25–35.

[20] Constantino LC, Binder LB, Vandresen-Filho S, Viola GG, Ludka FK, Lopes MW, et al. Role of phosphatidylinositol-3 kinase pathway in NMDA preconditioning: Different mechanisms for seizures and hippocampal neuronal degeneration induced by quinolinic acid. Neurotox Res 2018; 34: 452–462.

[21] Zhao Zh, Li X, Wang Y, Liu Ch, Ling G, Zhang P. Biomimetic platelet-camouflaged drug-loaded polypyrrole for the precise targeted antithrombotic therapy. J Nanobiotechnol 2023; 21: 439.

[22] Wan T, Zhang F-Sh, Qin M-Y, Jiang H-R, Zhang M, Qu Y, et al. Growth factors: Bioactive macromolecular drugs for peripheral nerve injury treatment molecular mechanisms and delivery platforms. Biomed Pharmacother 2024; 170: 116024.

[23] Morén C, deSouza RM, Giraldo DM, Uff Ch. Antioxidant therapeutic strategies in neurodegenerative diseases. Int J Mol Sci 2022; 23: 9328.

[24] Lee KH, Cha M, Lee BH. Neuroprotective effect of antioxidants in the brain. Int J Mol Sci 2020; 21: 7152.

[25] Li Z, Wang Q, Hu H, Zheng W, Gao C. Research advances of biomaterials-based microenvironment-regulation therapies for repair and regeneration of spinal cord injury. Biomed Mater 2021; 16: 5.

[26] Kaplan AA, Önger ME, Kaplan S. The effects of curcumin and blueberry on axonal regeneration after peripheral nerve injury. J Chem Neuroanat 2023; 130: 102260.

[27] Zavala A, Martinez PC, Gutierrez GG, Vara MD, De Pawlikowski W. The combined use of curcumin and platelet-rich plasma enhances axonal regeneration in acute nerve injuries: An experimental study in a rat model. J Hand Microsurg 2023; 15: 31–36.

[28] Chen N-F, Sung Ch-S, Wen Zh-H, Chen Ch-H, Feng Ch-W, Hung H-Ch. Therapeutic effect of platelet-rich plasma in rat spinal cord injuries. Front Neurosci 2018; 12: 252.

[29] Malheiro A, Seijas-Gamardo A, Harichandan A, Mota C, Wieringa P, Moroni L. Development of an in vitro biomimetic peripheral neurovascular platform. ACS Appl Mater Interfaces 2022; 14: 31567–31585.

[30] Sills ES, Wood SH. Autologous activated platelet-rich plasma injection into adult human ovary tissue: Molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep 2019; 39: BSR20190805.

[31] Tao Sh-C, Yuan T, Rui B-Y, Zhu Zh-Zh, Guo Sh-Ch, Zhang Ch-Q. Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/Bad/Bcl-2 signal pathway. Theranostics 2017; 7: 733–750.

[32] Lu Ch-F, Wang B, Zhang P-X, Han Sh, Pi W, Kou Y-H, et al. Combining chitin biological conduits with small autogenous nerves and platelet-rich plasma for the repair of sciatic nerve defects in rats. CNS Neurosci Ther 2021; 27: 805–819.

[33] Radithia D, Winias S, Parmadianti AE, Soebadi B, Ernawati DS, Hadi P. Inducing schwann cells increase using freeze-dried USING platelet-rich plasma for chronic constriction nerve injury in rat model. Biochem Cell Arch 2020; 20: 3119–3124.

[34] Zheng C, Zhu Q, Liu X, Huang X, He C, Jiang L, et al. Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. J Tissue Eng Regen Med 2016; 10: 428–436.

[35] Kim Y, Zharkinbekov Zh, Raziyeva K, Tabyldiyeva L, Berikova K, Zhumagul D, et al. Chitosan-based biomaterials for tissue regeneration. Pharmaceutics 2023; 15: 807.

[36] Wang S, Liu X, Wang Y. Evaluation of platelet-rich plasma therapy for peripheral nerve regeneration: A critical rev of literature. Front Bioeng Biotechnol 2022; 10: 808248.

[37] Wang S-L, Liu X-L, Kang Z-C, Wang Y-S. Platelet-rich plasma promotes peripheral nerve regeneration after sciatic nerve injury. Neural Regen Res 2023; 18: 375–381.